- Home
- VALN vs KURA Comparison
VALN vs KURA Comparison
Compare VALN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- KURA
- Stock Information
- Founded
- VALN 2012
- KURA 2014
- Country
- VALN France
- KURA United States
- Employees
- VALN N/A
- KURA N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VALN Health Care
- KURA Health Care
- Exchange
- VALN Nasdaq
- KURA Nasdaq
- Market Cap
- VALN 542.5M
- KURA 561.9M
- IPO Year
- VALN 2021
- KURA N/A
- Fundamental
- Price
- VALN $6.59
- KURA $6.13
- Analyst Decision
- VALN Strong Buy
- KURA Strong Buy
- Analyst Count
- VALN 3
- KURA 12
- Target Price
- VALN $15.33
- KURA $24.50
- AVG Volume (30 Days)
- VALN 14.9K
- KURA 1.4M
- Earning Date
- VALN 08-12-2025
- KURA 08-07-2025
- Dividend Yield
- VALN N/A
- KURA N/A
- EPS Growth
- VALN N/A
- KURA N/A
- EPS
- VALN N/A
- KURA N/A
- Revenue
- VALN $201,099,222.00
- KURA $67,991,000.00
- Revenue This Year
- VALN $18.74
- KURA $125.04
- Revenue Next Year
- VALN $29.26
- KURA $83.75
- P/E Ratio
- VALN N/A
- KURA N/A
- Revenue Growth
- VALN 21.64
- KURA N/A
- 52 Week Low
- VALN $3.62
- KURA $5.41
- 52 Week High
- VALN $8.66
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- VALN 72.04
- KURA 51.23
- Support Level
- VALN $5.82
- KURA $5.65
- Resistance Level
- VALN $6.19
- KURA $6.51
- Average True Range (ATR)
- VALN 0.31
- KURA 0.27
- MACD
- VALN 0.11
- KURA 0.06
- Stochastic Oscillator
- VALN 100.00
- KURA 59.68
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.